Published on
Feb 21, 2021
Phase 3 trials almost over, Dr Reddy’s seeks emergency use nod for Sputnik V
Dr Reddy’s Laboratories (DRL) said Friday it has approached the apex drug regulatory body for emergency approval of Sputnik V. If cleared by an expert body under the Central Drugs Standard Control Organisation (CDSCO), it would not only become the third …
Source:
The Indian Express
-
Neutral
